Rehabilitation Treatment of Patients With COVID-19

COVID-19 Clinical Trial

— COVID-REHAB  

Official title:

Rehabilitation Treatment of Patients With COVID-19 in an Infectious Diseases Hospital, Selection of Patients and Efficacy Criteria: A Retrospective Study With Propensity Score Matching.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05808361
• Other study ID #: COVID-REHAB
• Status: Completed
• Phase: N/A
• Start date: April 1, 2020
• Est. completion date: June 15, 2021

Study information

• Verified date: April 2023
• Source: I.M. Sechenov First Moscow State Medical University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is single centre retrospective study with propensity score matching. The aim of the study is to develop criteria for determining groups of patients with a new coronavirus infection based on clinical, laboratory and instrumental data for whom rehabilitation programs (physical exercises, chest massage in an electrostatic field) will be effective. Data on predictors of effective rehabilitation in COVID-19 is limited. Knowledge of predictors of possibility and efficacy of rehabilitation programs could enhance patients recovery. The main symptoms of COVID-19 involve the respiratory system and psychological function. Early rehabilitation can reduce hospital length of stay. Different patients have different degrees of dysfunction; therefore, personal plans should be developed according to the patient's age, sex, lifestyle and physical condition. Regular follow-up and rehabilitation guidance were conducted for discharged patients, focusing on improving vital capacity and cardiopulmonary endurance. There is a clear consensus that early rehabilitation is an important strategy for the treatment of polyneuropathy and myopathy in critical disease, to facilitate and improve long-term recovery and patients' functional independence, and to reduce the duration of respiratory support and hospitalization. Early rehabilitation and exercise prescriptions remain to be further optimized, especially for hospitalised patients.

Description:

The application of early rehabilitation can promote recovery of body functions; however, further studies are needed to determine the patient selection criteria and relevant mode of rehabilitation program.

A primary concern is regarding the timing of when to start a rehabilitation protocol in the face of the real threat of COVID-19.

Rehabilitation programs include physical exercises, and chest massage in an electrostatic field, started in the first 3 days after the patient's body temperature returned to normal.

The demographic and clinical data will be collected. Laboratory data (white blood cells count, C-reactive protein), and Instrumental data (pulse oxymetry, CT-scan) will be analysed. Rehabilitation evaluation - Health profile according to the quality of life questionnaire before and after each rehabilitation mode will be analysed. Exercise termination criteria: (1) Fluctuations in body temperature > 37.2°C; (2) respiratory symptoms and fatigue worsen; (3) chest tightness, chest pain, breathing difficulties, severe cough, dizziness, headache, blurred vision, palpitations, sweating, trouble standing.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 180
• Est. completion date: June 15, 2021
• Est. primary completion date: June 15, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• patients with COVID-19 admitted to the hospital with mild or moderate COVID-19 (5-50% of lung damage according to CT-scan)

Exclusion Criteria:

• less than 7 days in hospital by any reason,

• chronic decompensated diseases with extrapulmonary organ dysfunction (tumour progression, liver cirrhosis, congestive heart failure), admission to ICU, atonic coma,

• patients in whom more than 30 days have passed since the onset of the disease and before hospitalization,

• patients who received treatment in the intensive care unit, as well as patients who died.

Related Conditions & MeSH terms

• COVID-19
• Pneumonia, Viral
• Quality of Life
• Rehabilitation

Intervention

Other:
• exercises
The complex of therapeutic exercises included exercises in the initial position lying, sitting and standing. In active and static motor modes under the control of saturation, blood pressure, heart rate and respiratory rate. The complex included breathing exercises with the inclusion of compensatory respiratory muscles, elements of sound and drainage gymnastics, and diaphragmatic breathing. Therapeutic gymnastics was carried out in the form of individual lessons with an exercise therapy instructor, a course of 10 procedures, daily, the duration was 20 minutes.
• massage
Hardware massage in the electrostatic field with a frequency of 30/60 Hz of the chest area consisted of 10 procedures, daily, the duration of the procedure was 20 minutes.

Locations

Country	Name	City	State
Russian Federation	Clinical Hospital "MEDSI" in Otradnoe	Moscow

Sponsors (2)

Lead Sponsor	Collaborator
I.M. Sechenov First Moscow State Medical University	MEDSI Clinical Hospital 1, ICU

Country where clinical trial is conducted

Russian Federation, 

References & Publications (2)

Demeco A, Marotta N, Barletta M, Pino I, Marinaro C, Petraroli A, Moggio L, Ammendolia A. Rehabilitation of patients post-COVID-19 infection: a literature review. J Int Med Res. 2020 Aug;48(8):300060520948382. doi: 10.1177/0300060520948382. — View Citation

Sun T, Guo L, Tian F, Dai T, Xing X, Zhao J, Li Q. Rehabilitation of patients with COVID-19. Expert Rev Respir Med. 2020 Dec;14(12):1249-1256. doi: 10.1080/17476348.2020.1811687. Epub 2020 Oct 12. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Length of stay in hospital	length of stay in hospital	30 days
Secondary	complete blood count	white blood cells	Change of white blood cells from baseline on day 7 during treatment
Secondary	complete blood count dynamics	white blood cells	Change of white blood cells from 7 to 14 day during treatment
Secondary	Complaints of fatigue	Complaints of fatigue	Change of complains from baseline on day 7 during treatment
Secondary	Complaints of fatigue dynamics	Complaints of fatigue	Change of complains from 7 to 14 day during treatment
Secondary	Biochemistry analysis	C-reactive protein (CRP)	Change of CRP from baseline on day 7 during treatment
Secondary	Biochemistry analysis dynamics	C-reactive protein (CRP)	Change of CRP from 7 to 14 day during treatment